Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

543 ARTÍCULOS , VIENDO DEL 46 AL 60

Potential of flavonoids as anti-Alzheimer's agents: bench to bedside

Kaur R, Sood A, Lang DK, Bhatia S, Al-Harrasi A, Aleya L, Behl T.

Environ Sci Pollut Res Int. 2022 Apr;29(18):26063-26077. doi: 10.1007/s11356-021-18165-z. Epub 2022 Jan 24.

Progress in the development of naturally derived active metabolites-based drugs: Potential therapeutics for Alzheimer's disease

Mani R, Sha Sulthana A, Muthusamy G, Elangovan N.

Biotechnol Appl Biochem. 2022 Dec;69(6):2713-2732. doi: 10.1002/bab.2317. Epub 2022 Feb 8.

A New Perspective on the Treatment of Alzheimer's Disease and Sleep Deprivation-Related Consequences: Can Curcumin Help?

Küpeli Akkol E, Bardakcı H, Yücel Ç, Şeker Karatoprak G, Karpuz B, Khan H.

Oxid Med Cell Longev. 2022 Jan 12;2022:6168199. doi: 10.1155/2022/6168199. eCollection 2022.

Regulation of microRNAs in Alzheimer´s disease, type 2 diabetes, and aerobic exercise training

De Sousa RAL, Improta-Caria AC.

Metab Brain Dis. 2022 Mar;37(3):559-580. doi: 10.1007/s11011-022-00903-y. Epub 2022 Jan 25.

Exploring the dual character of metformin in Alzheimer's disease

Ning P, Luo A, Mu X, Xu Y, Li T.

Neuropharmacology. 2022 Apr 1;207:108966. doi: 10.1016/j.neuropharm.2022.108966. Epub 2022 Jan 22.

Tau protein aggregation: Key features to improve drug discovery screening

Giovannini J, Smeralda W, Jouanne M, Sopkova-de Oliveira Santos J, Catto M, Voisin-Chiret AS.

Drug Discov Today. 2022 May;27(5):1284-1297. doi: 10.1016/j.drudis.2022.01.009. Epub 2022 Jan 24.

Advances in prodrug design for Alzheimer's disease: the state of the art

Travers-Lesage V, Mignani SM, Dallemagne P, Rochais C.

Expert Opin Drug Discov. 2022 Apr;17(4):325-341. doi: 10.1080/17460441.2022.2031972. Epub 2022 Feb 23.

Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential

Gao L, Zhang Y, Sterling K, Song W.

Transl Neurodegener. 2022 Jan 28;11(1):4. doi: 10.1186/s40035-022-00279-0.

Alzheimer's disease therapy based on acetylcholinesterase inhibitor/blocker effects on voltage-gated potassium channels

Li XT.

Metab Brain Dis. 2022 Mar;37(3):581-587. doi: 10.1007/s11011-022-00921-w. Epub 2022 Jan 31.

Compared of efficacy and safety of high-dose donepezil vs standard-dose donepezil among elderly patients with Alzheimer's disease: a systematic review and meta-analysis

Wang H, Zong Y, Han Y, Zhao J, Liu H, Liu Y.

Expert Opin Drug Saf. 2022 Mar;21(3):407-415. doi: 10.1080/14740338.2022.2027905. Epub 2022 Jan 31.

Developing a pathway to support the appropriate, affordable, and widespread use of effective Alzheimer's prevention drugs

Reiman EM, Mattke S, Kordower JH, Khachaturian ZS, Khachaturian AS.

Alzheimers Dement. 2022 Jan;18(1):7-9. doi: 10.1002/alz.12533. Epub 2022 Feb 1.

The calcium-free form of atorvastatin inhibits amyloid-β(1-42) aggregation in vitro

Nedaei H, Rezaei-Ghaleh N, Giller K, Becker S, Karami L, Moosavi-Movahedi AA, Griesinger C, Saboury AA.

J Biol Chem. 2022 Mar;298(3):101662. doi: 10.1016/j.jbc.2022.101662. Epub 2022 Jan 30.

Human iPSC-Derived Neural Models for Studying Alzheimer's Disease: from Neural Stem Cells to Cerebral Organoids

Barak M, Fedorova V, Pospisilova V, Raska J, Vochyanova S, Sedmik J, Hribkova H, Klimova H, Vanova T, Bohaciakova D.

Stem Cell Rev Rep. 2022 Feb;18(2):792-820. doi: 10.1007/s12015-021-10254-3. Epub 2022 Feb 2.

Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer's disease

Taliyan R, Kakoty V, Sarathlal KC, Kharavtekar SS, Karennanavar CR, Choudhary YK, Singhvi G, Riadi Y, Dubey SK, Kesharwani P.

J Control Release. 2022 Mar;343:528-550. doi: 10.1016/j.jconrel.2022.01.044. Epub 2022 Jan 31.

Physiology and pharmacology of amyloid precursor protein

Cho Y, Bae HG, Okun E, Arumugam TV, Jo DG.

Pharmacol Ther. 2022 Jul;235:108122. doi: 10.1016/j.pharmthera.2022.108122. Epub 2022 Feb 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias